Aspivix offers Carevix®, an FDA‑cleared, CE‑marked soft‑suction cervical stabilizer that replaces the traditional tenaculum in transcervical procedures. By using a gentle vacuum grip and one‑button release, the device reduces patient pain by over 70 % and bleeding by more than 80 % while maintaining procedural control, helping gynecologists improve comfort and efficiency during IUD insertions, hysteroscopies, and related procedures.
Funding
$7.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
FFHLAZRFounders
Product
Problem
Gynecological procedures such as intrauterine device (IUD) insertion rely on the cervical tenaculum, a century‑old instrument with sharp hooks that pierces cervical tissue, causing significant pain, bleeding, and patient anxiety. This discomfort discourages many women from choosing effective contraceptive methods.
Solution
Aspivix has developed Carevix®, a soft‑suction cervical stabilizer that replaces the tenaculum with a gentle vacuum‑based grip. The device securely holds the cervix during transcervical procedures and releases with a button press, eliminating tissue puncture. Clinical studies show reductions of over 70 % in pain and more than 80 % in bleeding compared with traditional forceps, while maintaining procedural control. Carevix® is FDA‑cleared, CE‑marked, and available for commercialization in the United States and several international markets, offering clinicians a validated, patient‑centered alternative for IUD insertions, hysteroscopies, embryo transfers, IUIs, and endometrial biopsies.
Target Audience
Primary customers are gynecologists, obstetricians, and reproductive health clinics performing IUD insertions and other transcervical procedures, as well as hospital systems and ambulatory surgery centers seeking to improve patient comfort and procedural efficiency.
Features
- Soft‑suction mechanism that gently grasps the cervix without sharp hooks, reducing tissue trauma
- One‑button release of vacuum for rapid, controlled disengagement
- Compatible with standard transcervical instruments and workflows
- Clinically proven efficacy: >70 % pain reduction and >80 % bleeding reduction in multicenter studies
- FDA‑cleared (K223866) and CE‑marked, supporting use in US and EU markets
- Training program (on‑site or online) for physicians and residents to ensure proper device adoption
- Reusable device with sterilizable components, minimizing per‑procedure consumable costs